NCT05497856

Comparison of Integrated Neuromuscular Inhibition Technique With Myofascial Release on Rhomboids Trigger Points

Completed NA Last updated 9 November 2022

What this trial tests

NA trial testing Integrated neuromuscular inhibition technique in Trigger Point Pain, Myofascial in 32 participants. Completed in 30 September 2022.

Timeline

10 August 2022

Primary endpoint
15 September 2022

30 September 2022

Quick facts

Lead sponsor	Riphah International University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	32
Start date	10 August 2022
Primary completion	15 September 2022
Estimated completion	30 September 2022
Sites	1 location across Pakistan

Drugs / interventions tested

• Integrated neuromuscular inhibition technique
• Myofascial Release

Conditions studied

• Trigger Point Pain, Myofascial — all drugs for Trigger Point Pain, Myofascial →

Sponsor

Riphah International University

Who can join

Adults 25 to 45, any sex, with Trigger Point Pain, Myofascial. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this research is to compare the effect of integrated neuromuscular inhibition technique and myofascial release on pain, pain pressure threshold and shoulder disability in patients with rhomboid muscle. Randomized controlled trials will be done at Benazir Bhutto Hospital. The sample size is 32. The subjects will be divided in two groups, 16 subjects in integrated neuromuscular inhibition technique group and 16 in myofascial release group. Study duration will be of 6 months. Sampling technique applied will be non-probability purposive sampling technique. Only 25-45 years patients with shoulder/mid back pain and the presence of atleast one trigger point in rhomboid muscles will be included. Tools used in the study are algometer, shoulder pain and disability index (SPADI) and Numeric pain rating scale (NPRS). Data will be analyzed through SPSS 21.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.